219 related articles for article (PubMed ID: 16049014)
1. Identification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analyses.
Mazerbourg S; Sangkuhl K; Luo CW; Sudo S; Klein C; Hsueh AJ
J Biol Chem; 2005 Sep; 280(37):32122-32. PubMed ID: 16049014
[TBL] [Abstract][Full Text] [Related]
2. Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands.
Mazerbourg S; Hsueh AJ
Hum Reprod Update; 2006; 12(4):373-83. PubMed ID: 16603567
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
5. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
[TBL] [Abstract][Full Text] [Related]
6. BMP and activin receptor expression in lens development.
de Iongh RU; Chen Y; Kokkinos MI; McAvoy JW
Mol Vis; 2004 Aug; 10():566-76. PubMed ID: 15346106
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein receptor type II is a receptor for growth differentiation factor-9.
Vitt UA; Mazerbourg S; Klein C; Hsueh AJ
Biol Reprod; 2002 Aug; 67(2):473-80. PubMed ID: 12135884
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between bone morphogenetic protein and transforming growth factor-beta signaling is essential for exendin-4-induced insulin-positive differentiation of AR42J cells.
Yew KH; Hembree M; Prasadan K; Preuett B; McFall C; Benjes C; Crowley A; Sharp S; Tulachan S; Mehta S; Tei E; Gittes G
J Biol Chem; 2005 Sep; 280(37):32209-17. PubMed ID: 16020542
[TBL] [Abstract][Full Text] [Related]
9. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways.
Nohe A; Hassel S; Ehrlich M; Neubauer F; Sebald W; Henis YI; Knaus P
J Biol Chem; 2002 Feb; 277(7):5330-8. PubMed ID: 11714695
[TBL] [Abstract][Full Text] [Related]
10. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells.
Yu PB; Beppu H; Kawai N; Li E; Bloch KD
J Biol Chem; 2005 Jul; 280(26):24443-50. PubMed ID: 15883158
[TBL] [Abstract][Full Text] [Related]
12. Receptor expression modulates the specificity of transforming growth factor-beta signaling pathways.
Murakami M; Kawachi H; Ogawa K; Nishino Y; Funaba M
Genes Cells; 2009 Apr; 14(4):469-82. PubMed ID: 19335617
[TBL] [Abstract][Full Text] [Related]
13. Specification of BMP Signaling.
Nickel J; Mueller TD
Cells; 2019 Dec; 8(12):. PubMed ID: 31817503
[TBL] [Abstract][Full Text] [Related]
14. Menin suppresses osteoblast differentiation by antagonizing the AP-1 factor, JunD.
Naito J; Kaji H; Sowa H; Hendy GN; Sugimoto T; Chihara K
J Biol Chem; 2005 Feb; 280(6):4785-91. PubMed ID: 15563473
[TBL] [Abstract][Full Text] [Related]
15. DRAGON, a bone morphogenetic protein co-receptor.
Samad TA; Rebbapragada A; Bell E; Zhang Y; Sidis Y; Jeong SJ; Campagna JA; Perusini S; Fabrizio DA; Schneyer AL; Lin HY; Brivanlou AH; Attisano L; Woolf CJ
J Biol Chem; 2005 Apr; 280(14):14122-9. PubMed ID: 15671031
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling.
Matsumoto Y; Otsuka F; Hino J; Miyoshi T; Takano M; Miyazato M; Makino H; Kangawa K
Mol Cell Endocrinol; 2012 Mar; 350(1):78-86. PubMed ID: 22155034
[TBL] [Abstract][Full Text] [Related]
17. BMP-2/ALK3 and HGF signal in parallel to regulate renal collecting duct morphogenesis.
Gupta IR; Macias-Silva M; Kim S; Zhou X; Piscione TD; Whiteside C; Wrana JL; Rosenblum ND
J Cell Sci; 2000 Jan; 113 Pt 2():269-78. PubMed ID: 10633078
[TBL] [Abstract][Full Text] [Related]
18. Endoglin is involved in BMP-2-induced osteogenic differentiation of periodontal ligament cells through a pathway independent of Smad-1/5/8 phosphorylation.
Ishibashi O; Ikegame M; Takizawa F; Yoshizawa T; Moksed MA; Iizawa F; Mera H; Matsuda A; Kawashima H
J Cell Physiol; 2010 Feb; 222(2):465-73. PubMed ID: 19918795
[TBL] [Abstract][Full Text] [Related]
19. BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation.
Moser M; Binder O; Wu Y; Aitsebaomo J; Ren R; Bode C; Bautch VL; Conlon FL; Patterson C
Mol Cell Biol; 2003 Aug; 23(16):5664-79. PubMed ID: 12897139
[TBL] [Abstract][Full Text] [Related]
20. BMP10 as a potent inducer of trophoblast differentiation in human embryonic and induced pluripotent stem cells.
Lichtner B; Knaus P; Lehrach H; Adjaye J
Biomaterials; 2013 Dec; 34(38):9789-802. PubMed ID: 24070570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
